In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Olga IlinskayaMicrobiology Department, Institute of Fundamental Medicine and Biology of Kazan (Volga-Region) Federal University, Kazan Federal University, Kremlevskaya St., 18, Kazan 420008, Russia.ORCID 0000-0001-6936-2032 Galina YakovlevaMicrobiology Department, Institute of Fundamental Medicine and Biology of Kazan (Volga-Region) Federal University, Kazan Federal University, Kremlevskaya St., 18, Kazan 420008, Russia.ORCID 0000-0002-8504-3434 Pavel ZelenikhinMicrobiology Department, Institute of Fundamental Medicine and Biology of Kazan (Volga-Region) Federal University, Kazan Federal University, Kremlevskaya St., 18, Kazan 420008, Russia.ORCID 0000-0003-1971-1745 Alexey KolpakovMicrobiology Department, Institute of Fundamental Medicine and Biology of Kazan (Volga-Region) Federal University, Kazan Federal University, Kremlevskaya St., 18, Kazan 420008, Russia.ORCID 0000-0001-9742-5512 William KurdyMicrobiology Department, Institute of Fundamental Medicine and Biology of Kazan (Volga-Region) Federal University, Kazan Federal University, Kremlevskaya St., 18, Kazan 420008, Russia.ORCID 0009-0005-9405-3019 Mikhail GlukhovMineralogy and Lithology Department, Institute of Geology and Oil and Gas Technologies of Kazan (Volga-Region) Federal University, Kazan Federal University, Kremlevskaya St., 4/5, Kazan 420111, Russia.ORCID 0000-0002-5075-7066 Igor SedovLaboratory of Molecular Basis of Amyloid Formation and Antiamyloid Activity of Chemical Institute Named After A.M. Butlerov of Kazan (Volga-Region) Federal University, Kazan Federal University, Kremlevskaya St., 29, Kazan 420111, Russia.ORCID 0000-0003-0438-5991 Sergey KharintsevOptics and Nanophotonics Department, Institute of Physics of Kazan (Volga-Region) Federal University, Kazan Federal University, Kremlevskaya St., 18, Kazan 420008, Russia.ORCID 0000-0002-5788-3401 Funding
Russian Science Foundation 24-14-00059
6 · The paper itselfAbstract
Blocking the MAPK pathway is a strategy to stop cancer cells proliferation. Despite all the successes, the acquisition of drug resistance by cells, as well as the mutational status of the downstream protein KRAS, reduces the tumor response to therapy. Ribonuclease binase from
Indexed as
Antineoplastic AgentsEndoribonucleasesCell Line, TumorCell ProliferationHumansZeolitesAntineoplastic AgentsEndoribonucleasesribonuclease T(2)Zeolitesantitumor activitybinasecytotoxicityhuman adenocarcinoma cellsporosityprolonged enzyme releasestabilityzeolite
Identifiers
PMID41009766
PMCPMC12470943
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390